Skip to Content
Merck

[Drug treatments, from chlorpromazine to new molecules].

Soins. Psychiatrie (2013-06-14)
Adeline Gaillard, Marie-France Poirier
ABSTRACT

The history of drug treatments, and particularly the discovery of certain molecules, led toan evolution in psychiatric practices. The discovery of the therapeutic properties of chlorpromazine in 1952 by Jean Delay and Pierre Deniker revolutionised the relational process between patients and caregivers.The perspectives are encouraging, notably in the areas of schizophrenia and mood disorders.

MATERIALS
Product Number
Brand
Product Description

Supelco
Chlorpromazine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Chlorpromazine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
Chlorpromazine hydrochloride, VETRANAL®, analytical standard
Sigma-Aldrich
Chlorpromazine hydrochloride, meets USP testing specifications
Sigma-Aldrich
Chlorpromazine hydrochloride, ≥98% (TLC)